TRUQAP

Identification of Truqap

No description

Google image searchProduct monograph

Active ingredient

capivasertib, 160 MG

DIN: 02544733

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 16-APR-2024

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX27 — CAPIVASERTIB (ATC/DDD)

Reference brand drug: Truqap

External Links for Truqap

Search on Google

• Truqap side effects
• Truqap dosage
• capivasertib side effects
• capivasertib dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find truqap photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.